HPV vaccine indicated for treating anal cancers
The European Commission has approved the use of Gardasil – the quadrivalent human papillomavirus vaccine – for preventing anal precancerous lesions and anal cancers that are causally related to certain oncogenic HPV types in men and women.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units